Literature DB >> 22446380

APOBEC3B and AID have similar nuclear import mechanisms.

Lela Lackey1, Zachary L Demorest, Allison M Land, Judd F Hultquist, William L Brown, Reuben S Harris.   

Abstract

Members of the APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) protein family catalyze DNA cytosine deamination and underpin a variety of immune defenses. For instance, several family members, including APOBEC3B (A3B), elicit strong retrotransposon and retrovirus restriction activities. However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization. Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase). Mechanistic conservation with AID is further suggested by A3B's capacity to interact with the same subset of importin proteins. Despite these mechanistic similarities, enforced A3B expression cannot substitute for AID-dependent antibody gene diversification by class switch recombination. Regulatory differences between A3B and AID are also visible during cell cycle progression. Our studies suggest that the present-day A3B enzyme retained the nuclear import mechanism of an ancestral AID protein during the expansion of the APOBEC3 locus in primates. Our studies also highlight the likelihood that, after nuclear import, specialized mechanisms exist to guide these enzymes to their respective physiological substrates and prevent gratuitous chromosomal DNA damage.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446380      PMCID: PMC3368237          DOI: 10.1016/j.jmb.2012.03.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  82 in total

1.  APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.

Authors:  Igor B Rogozin; Malay K Basu; I King Jordan; Youri I Pavlov; Eugene V Koonin
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

2.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

3.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Authors:  Hal P Bogerd; Heather L Wiegand; Amy E Hulme; José L Garcia-Perez; K Sue O'Shea; John V Moran; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-25       Impact factor: 11.205

4.  The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.

Authors:  Kristina Krause; Kenneth B Marcu; Jobst Greeve
Journal:  Mol Immunol       Date:  2005-06-15       Impact factor: 4.407

5.  APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.

Authors:  Mark D Stenglein; Reuben S Harris
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

Review 6.  AID and Igh switch region-Myc chromosomal translocations.

Authors:  Shyam Unniraman; David G Schatz
Journal:  DNA Repair (Amst)       Date:  2006-06-19

7.  Structural phylogenetic analysis of activation-induced deaminase function.

Authors:  H Travis Ichikawa; Mark P Sowden; Andrew T Torelli; Jürgen Bachl; Pinwei Huang; Geoffrey S C Dance; Shauna H Marr; Jacques Robert; Joseph E Wedekind; Harold C Smith; Andrea Bottaro
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

8.  All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.

Authors:  Masanobu Kinomoto; Takayuki Kanno; Mari Shimura; Yukihito Ishizaka; Asato Kojima; Takeshi Kurata; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

9.  Population stratification of a common APOBEC gene deletion polymorphism.

Authors:  Jeffrey M Kidd; Tera L Newman; Eray Tuzun; Rajinder Kaul; Evan E Eichler
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

10.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes.

Authors:  Anne E Carpenter; Thouis R Jones; Michael R Lamprecht; Colin Clarke; In Han Kang; Ola Friman; David A Guertin; Joo Han Chang; Robert A Lindquist; Jason Moffat; Polina Golland; David M Sabatini
Journal:  Genome Biol       Date:  2006-10-31       Impact factor: 13.583

View more
  47 in total

1.  APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction.

Authors:  Daniel J Salamango; Jordan T Becker; Jennifer L McCann; Adam Z Cheng; Özlem Demir; Rommie E Amaro; William L Brown; Nadine M Shaban; Reuben S Harris
Journal:  Mol Cell Biol       Date:  2018-11-13       Impact factor: 4.272

2.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

3.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Authors:  Rebecca M McDougle; Judd F Hultquist; Alex C Stabell; Sara L Sawyer; Reuben S Harris
Journal:  Virology       Date:  2013-03-29       Impact factor: 3.616

4.  Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Authors:  Allison M Land; Emily K Law; Michael A Carpenter; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

5.  Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Bioessays       Date:  2014-02-26       Impact factor: 4.345

Review 6.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

7.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Authors:  In-Ja L Byeon; Chang-Hyeock Byeon; Tiyun Wu; Mithun Mitra; Dustin Singer; Judith G Levin; Angela M Gronenborn
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

8.  APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

Authors:  Brandon Leonard; Steven N Hart; Michael B Burns; Michael A Carpenter; Nuri A Temiz; Anurag Rathore; Rachel I Vogel; Jason B Nikas; Emily K Law; William L Brown; Ying Li; Yuji Zhang; Matthew J Maurer; Ann L Oberg; Julie M Cunningham; Viji Shridhar; Debra A Bell; Craig April; David Bentley; Marina Bibikova; R Keira Cheetham; Jian-Bing Fan; Russell Grocock; Sean Humphray; Zoya Kingsbury; John Peden; Jeremy Chien; Elizabeth M Swisher; Lynn C Hartmann; Kimberly R Kalli; Ellen L Goode; Hugues Sicotte; Scott H Kaufmann; Reuben S Harris
Journal:  Cancer Res       Date:  2013-10-23       Impact factor: 12.701

9.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

Review 10.  The APOBEC3 family of retroelement restriction factors.

Authors:  Eric W Refsland; Reuben S Harris
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.